Skip to main content
Premium Trial:

Request an Annual Quote

Applied DNA Sciences and DOE to Develop PCR-Based DNA Detection Technology

NEW YORK, Dec. 21 (GenomeWeb News) - Applied DNA Sciences has signed a Cooperative Research and Development Agreement with the US Department of Energy to develop tools for rapid DNA analysis, the company said yesterday.


Under the CRADA, scientists and engineers at the DOE plan to improve DNA testing methods that build on PCR for detecting DNA recovered from materials that were spiked with DNA. Using DNA as a marker "requires a method of detection and analysis that is faster and cheaper over that which is commercially available today," said Paul Reep, the company's chief technology officer, in a statement.


Applied DNA Sciences, based in Los Angeles, develops methods to use DNA as an identifier to prevent counterfeiting, fraud, or piracy.

The Scan

Lung Cancer Response to Checkpoint Inhibitors Reflected in Circulating Tumor DNA

In non-small cell lung cancer patients, researchers find in JCO Precision Oncology that survival benefits after immune checkpoint blockade coincide with a dip in ctDNA levels.

Study Reviews Family, Provider Responses to Rapid Whole-Genome Sequencing Follow-up

Investigators identified in the European Journal of Human Genetics variable follow-up practices after rapid whole-genome sequencing.

BMI-Related Variants Show Age-Related Stability in UK Biobank Participants

Researchers followed body mass index variant stability with genomic structural equation modeling and genome-wide association studies of 40- to 72-year olds in PLOS Genetics.

Genome Sequences Reveal Range Mutations in Induced Pluripotent Stem Cells

Researchers in Nature Genetics detect somatic mutation variation across iPSCs generated from blood or skin fibroblast cell sources, along with selection for BCOR gene mutations.